86P Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
| Autor: | He, A.R., Valle, J.W., Lee, C-K., Ikeda, M., Potemski, P., Morizane, C., Cundom, J.E., Tougeron, D., Dayyani, F., Rokutanda, N., Xiong, J., Cohen, G., Oh, D-Y. |
|---|---|
| Zdroj: | In Annals of Oncology November 2022 33 Supplement 9:S1467-S1468 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|